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Abstract 
In spite of the emerging advances in the field of wound dressings, there is still a deep 
need for the development of novel natural based dressings to offer a safe alternative for 
traditional wound dressings and most importantly fight against antibacterial resistance. 
The aim of this study is to develop novel honey based nanofibrous wound dressing for 
achieving both effective and safe treatment and investigate the dressings for 
antibacterial activity, cytotoxicity and in vivo wound healing effect in a rat wound 
model. 
 
Natural products; Honey, Pomegranate peel extract (PPP), and bee venom (BV), known 
for their antibacterial and anti-inflammatory properties, were used in combination with 
Polyvinyl alcohol (PVA), to develop a novel natural-based nanofibrous wound 
dressing. Methanolic pomegranate peel extract was prepared and mixed with either 
Manuka honey (MH) or lyophilized multiflora honey powder (LH). By testing 
electrospun samples: (10% MH/ 1% PPP), (20% MH/ 2% PPP) and (25%/ 2.5%PPP) 
against S. aureus, it was shown that antibacterial activity increases with increasing the 
MH/PPP concentration. BV was added to the honey/PPP combination to prepare (25 % 
MH/2.5 % PPP/ 0.01%BV) and (25 % LH/2.5 % PPP/0.01% BV) nanofibers.  
 
Scanning electron microscopy (SEM) showed that all samples had good morphology 
with no beads. Samples showed moderate swelling capacity in comparison to PVA 
while all samples showed better water loss capacity than PVA. Antibacterial tests 
showed significant antibacterial activity against both strains tested compared to both 
controls used (P< 0.0001). Against S. aureus, samples containing BV were slightly 
more effective than the sample without BV (P < 0.05). Against E. coli, sample 
(MH/PPP/BV) was slightly more effective than sample (LH/PPP/BV) (P < 0.05). In the 
cytotoxicity assay, all samples showed 100 - 120 % viability which indicated that the 
produced dressings have no significant cytotoxic effects. Results of the in vivo wound 
healing assay showed that treatment groups (25% MH/2.5%PPP), (25% MH/2.5%PPP/ 
0.01 %BV), and (25% LH/2.5 %PPP/ 0.01% BV) had a significantly decreased wound 
surface areas compared to both controls at days 3 and day 5 (P <0.0001). All treatment 
groups reached complete healing by day 10 compared to day 14 in the case of both 
controls. On the histological side, PVA control group showed poor healing compared 
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to all treatment groups. MH/PPP/BV sample micrographs showed excellent healing at 
day 10 resembling intact skin as shown by histological assessment. These results 
indicate that MH/PPP/BV combination can be considered as a promising formula to 
promote wound healing. However, further analysis is required to confirm the results 
and address the potential of the combination on more challenging wounds. 
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Chapter 1: Introduction and literature review 
 
1.1. Introduction 
Wounds are considered one of the critical public health problems in the world. In the 
United States alone, undertreated wounds and chronic wounds affected 6.5 million 
patients in 2009, with an annual cost in excess of 25 billion USD (Sen et al., 2009). In 
2011, the global market of wound-care products produced 6,500 million USD with 
7.5% annual growth rate. In 2023, the global advanced wound-care products market 
share is expected to reach nearly 16,300 million USD. Therefore, new technologies are 
essential to face this problem ((Sharma & Paul, 2015).  
Nano material scaffolds are among the promising wound dressings to improve wound 
healing. These scaffolds have better properties compared to conventional dressings 
such as having high porosity, very small pore size and large surface area to volume 
ratio. These properties lead to higher exudate absorption, better wound permeation and 
prevention from further infection (Huang et al., 2003). 
For decades, honey has been used as wound healing remedy in various forms, owing to 
its remarkable antimicrobial properties. Honey consists of water (20%), fructose (40%), 
glucose (30%), sucrose (5%), and other substances such as, minerals, vitamins, amino 
acids, and enzymes (Bagde et al., 2013). It was demonstrated from previous studies that 
honey has antibiotic, antimicrobial, and anti-inflammatory properties and inhibits a 
broad spectrum of bactericidal organisms (Chang et al., 2009, Pieper 2009).  Thereby, 
it has the advantage of providing a moist environment that is suitable for the healing 
process without the fear of an occurring bacterial growth. Moreover, honey is acidic 
therefore it is able to provide fibroblasts with optimal environment for their activity.  
The present study aims at testing multiple natural products loaded within honey/PVA 
nanofiber scaffold in order to improve wound healing activity in an animal model (Two 
types of honey were used MH and lyophilized multiflora honey powder). 
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1.2. Global impact 
In 2011, the global market of wound-care products produced 6,500 million USD with 
7.5% annual growth rate. This cost included nearly 230 million surgical procedures, 
chronic wounds (12–15 million leg ulcers, 9–11 million pressure sores) and an equal 
number of burn wounds yearly all over the world. Figure 1 shows the global prevalence 
of wounds according to wound type in 2011 and that predicted in 2025 (Sharma & Paul, 
2015). 
Despite the fact that surgical wounds showed the highest prevalence, It is expected that 
there will be a significant increase in number of chronic wounds whose wounds requires 
advanced wound care products. The market share for advanced wound-care dressings 
is expected to increase in Germany, Japan, USA, France, UK, Italy, Brazil, Russia, 
Spain, China and India. 
It is predicted that India will be the largest consumer for advanced wound care in the 
future. This might be attributed to the rise in lifestyle-related diseases such as diabetes 
as well as the raise in the economic status of the Indian population due to better health 
care policies and the fast-growing health insurance market. 3M, Smith & Nephew, 
Johnson & Johnson, Dr. Reddys and Beiserdorf are considered the main players in the 
field of wound-care dressings. In 2023, the global advanced wound-care products 
market share is expected to reach nearly 16,300 million USD. Another study, expected 
that the total global market share in 2014 that was worth 15,600 million USD will reach 
18,300 million USD in 2019 (Sharma & Paul, 2015). 
The predicted huge growth of the market stems from a raise in diabetes prevalence, 
presence of ageing populations, and obesity. These conditions lead to more chronic 
wounds and ulcers thereby causing considerable degree of possible mortality and 
morbidity, and also presenting a huge problem to the health care system as they are 
considered most costly wound types to treat. 
 
1.3. Wounds and their classification  
A wound can be defined as any cut or tear on the surface of the skin. Most commonly, 
wounds can be classified into acute wounds and chronic wounds, and into three types 
based on depth; first, superficial wounds that includes the epidermis layer, second, 
partial thickness wounds that include the epidermis along with the dermis layer and 
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third, full thickness wounds which include deeper layers being affected like the 
subcutaneous fat or even deeper layers ( Figure 2). 
Wounds can also be classified into wounds with tissue loss (e.g. burns, ulcer wounds, 
abrasions, pressure sores, iatrogenic wounds, trauma wounds) or without tissue loss like 
for example surgical wounds (Sharma & Paul, 2015). 
Acute wounds normally heal on their own. For example, cuts, lacerations, penetrations, 
avulsion, bites and burns are considered different types of acute wounds. On the other 
side, chronic wounds do not heal in a timely and structured manner. Therefore, a 
continued management is needed in case of chronic wounds. Most common types of 
chronic wounds include; a) Diabetic ulcer. b) Pressure ulcers or bedsores that results 
from prolonged pressure to some body parts, and c) Arterial and venous ulcers resulting 
from avascular dysfunction mainly in lower limbs, leading to reduced blood flow and 
chronic inflammation (Sharma & Paul, 2015). 
 
1.4. Wound healing process 
The process of wound healing is a complex process starting with hemostasis, followed 
by inflammation, proliferation and finally, remodeling (Figure 3). Generally, healing 
time taken from the beginning to end is between two to three weeks unless other factors 
that may prolong healing time took place. In the inflammation step following a blood 
vessel injury, involves coagulation as well as an acute local inflammatory response 
where monocytes, neutrophils, lymphocytes and macrophages are recruited to the site 
of injury. In the proliferation step, all cytokines and factors that were previously 
released in the inflammatory step enhance the proliferation of progenitor cells. 
Fibroblasts, keratinocytes as well as endothelial cells are recruited in this step leading 
to migration and proliferation of cells (Sharma & Paul, 2015). In the remodeling stage, 
cells start to migrate in order to re-epithelialize the damaged tissue at the wound’s edges 
in a process known as epithelial mesenchymal transition. After this, a scar tissue is 
formed where the wounds starts to contract and myofibroblasts are formed as a result 
of fibroblasts differentiation. As a result of the occurring angiogenesis, newly formed 
blood vessels appear and nerves begin to sprout (Stein & Küchler, 2013, Sharma & 
Paul., 2015). 
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1.5. Modern wound healing products classification 
Modern wound dressings were developed mainly to help in enhancing the healing 
process, rather than just creating a cover over the wound. These dressings are concerned 
with keeping wounds from dehydration as well as promoting healing. According to the 
nature of their action, modern wound healing products are classified into three main 
categories, passive, including traditional gauze or tulle wound dressings which 
represent the largest market segment, interactive and bioactive products.  Among the 
disadvantages of these passive forms of dressings is that they can disrupt the wounds 
when removed as they tend to stick to the wounds. That’s why this type of wounds will 
only suit minor wounds. Although tulle which is made of petroleum jelly does not stick 
to the wound like gauze, it suits flat wounds with little exudate.  
 
Interactive products are made from foams and polymeric films. They are considered 
permeable to water vapor and oxygen while being impermeable to bacteria. Foams has 
better exudate absorption than films and amorphous gels, that’s why they can be used 
for moderate exudate absorption unlike films and gels which are suitable for low 
exudate wounds.  A third type of products is represented by bioactive products, which 
delivers active components to the wound which contributes in the healing process. 
These components may include collagen, proteins, growth factors, alginates (Dhivya et 
al, 2015). 
Other types of modern wound dressings may include tissue engineered skin substitutes 
which can be made up of cells, ECM or combination of both. They can be divided into 
cellular and acellular skin substitutes (Rubaiy et al., 2009).  Medicated dressings 
generally are drugs-incorporated dressings. They help in the healing process either 
directly or indirectly by removing of the necrotic tissues. The dressings may contain 
antimicrobial agents that prevents infection or growth factors and enzymes which 
enhances regeneration. Composite dressing, can be called combination dressings that 
have multiple layers. Most composite dressings usually have three layers. An outer 
layer is designed to protect the wound against infection. A layer in the middle is usually 
composed of absorptive material which helps in autolytic debridement and in 
maintaining moisture environment while the third layer is supposed to be composed of 
non-adherent material so that it will not stick to the wound (Dhivya. et al, 2015).  
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1.6. Challenges in wound healing 
Management of wounds with a delayed healing time i.e. chronic or non-healing wounds 
is considered as the main challenge to wound care practitioners and researchers. The 
main reasons to delayed healing include systemic diseases, arterial insufficiency and 
aging. The factors affecting the healing process can vary between local and systemic 
factors. Among the local factors is infection, ischemia, tissue maceration and presence 
of foreign bodies inside the wound area. Among the systemic factors, there is 
malnutrition, diabetes, age and renal diseases. Controlling the effects of these factors is 
important for normal healing process to take place.  
 
In chronic wounds for example, there is a decreased level of growth factors such as 
Epidermal Growth Factor (EPGF), platelet driven growth factor, basic fibroblast 
growth factor and transforming growth factor that are crucial for the healing process to 
work properly possibly due to degradation or becoming in active. In aging, fibroblasts 
have poor responsiveness to nutrients and growth factors which result in chronic 
wounds. Abnormal degradation of the extracellular matrix (ECM) can happen as result 
of over expression of the matrix metalloproteinase due to an increased proteinase 
activity (Clark et al., 2007, Sharma & Paul, 2015). Failure of chronic wounds to heal in 
comparison to the acute healing process is shown in figure 4, on the left of the figure, 
acute injury of a tissue activates blood clotting, aggregation of platelets and migration 
of macrophages and neutrophils to the location of the injury. First, a blood clot is 
formed of fibrin and fibronecetin which acts as a scaffold for platelets and cell migration 
where growth factors are released. At day 3, the formed clot accumulates neutrophils 
which in turn help phagocytose micro-organisms. On the upper right of the figure, by 
day 5 after injury and under normal conditions, the wound continue the healing process 
with the help of the growing granulation tissue that is formed mainly of fibroblasts, 
more macrophages as well as neovasculature. The epidermis starts migrating towards 
newly forming tissue. On the lower right of the figure, when the wound fails to heal 
due to an underlying pathobiology or as a result of a microorganism invasion, the 
healing process is interrupted leading to a chronic wound or ulcer formation.  Many 
factors hinder the acute healing process including venous insufficiency which in turn 
leads to transudation of fluids and fibrin cuffing of venules as a result to increased 
venous system hydrostatic pressure. Other factor might be diabetes mellitus where high 
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glucose levels which leads to dysfunction of ECM due to the occurring non-enzymatic 
glycation. Among the factors also there is arterial occlusion or increased external 
pressure that results in hypoxia of tissues and cell dysfunction.  Bacteria might start to 
colonize the wound leading to the formation of biofilm which in turn worsen the 
condition by protecting the colonies of bacteria, becoming relatively resistant to 
phagocytic cells and antibiotics. Moreover, desperate phagocytes release proteases and 
toxic free oxygen radicals into the wound. This will worsen the condition even more as 
released agents start destroying the tissue cells, ECM, and growth factors in the wound. 
As a consequence of all these events, granulation tissue in growth and epidermal 
migration is absent in chronic wounds. 
Although that there a huge advancement in the knowledge and the science of wound 
healing together with the technical innovation, involvement of pharmaceutical 
companies, an array of resources ranging from dressings, tissue replacement and cell 
based treatment options being available however, the biggest challenge is dealing with 
chronic wounds in terms of practical training with the condition. Also, Scarring 
prevention as well as achieving a cosmetically acceptable way of wound healing 
remains a challenge for wound care professionals. Over the past four decades, an 
extensive research has been done on wound healing and wound dressings. The main 
reasons for applying a dressing can be summarized in leading to rapid as well as a 
cosmetically accepted way of healing, remove odor, prevent infection or fight infection, 
decrease pain, contain exudates, cover a wound for cosmetically accepted appearance, 
causing minimal distress to the patients (Sharma & Paul, 2015). 
 
1.7. Honey based dressings and Manuka honey 
Having a history in being an ancient remedy for healing burns and wounds, honey is 
still believed to help heal wounds faster and fight against infections. It is suggested that 
ancient Egyptians used honey around 3000 BC. The ‘three healing gestures” papyrus 
mentioned honey and included it as an integral part within the ancient healing process. 
The first wound dressings are believed to be made from honey, vegetable fiber and 
animal fat. In modern history, recognition of honey as a topical antibacterial agent 
started in 1892.  
Recently, there has been an interest in re-adopting the use of honey in wound healing 
especially with the emergence of the antibacterial resistance problem, in 2007, The US 
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Food and Drug Administration (FDA) approved the honey-based dressings 
MEDIHONEY® (Derma Sciences, Priceton, NJ), gel sheet where calcium alginate 
gelled with honey forming a rubbery layer similar hydrocolloids. The layer forms a 
softer gel when it absorbs the exudate and leaves a layer of honey in contact with the 
wound (Sharma & Paul, 2015). Other products like Algivon® dressings (Advancis 
Medical, Nottingham, UK) and Apinate TM dressings (Comvita® (Tepuke, New 
Zealand), honey- mechanically bonded calcium alginate fiber dressing), make a barrier 
protecting against pathogens. The outflow of exudates, induced by osmotic action, 
removes the wound bacteria, endotoxin debris and slough (Sharma & Paul, 2015). 
 
MH is produced by (Apis mellifera) honey bees foraging on the tea or Manuka tree 
(Leptospermum scoparium) which grows throughout New Zealand and 
southeastern Australia (Carter et al., 2009). MH is typically dark in color and 
considered markedly viscous compared to other honey types. This property is due to 
the presence of a colloid or protein which is considered as main visually defining 
character. 
 
Typically, honey contains many components that is responsible for its antimicrobial 
activity. As mentioned before in the introduction, honey has a high degree of osmolality 
owing to its high sugar content. In addition to this, the majority of honeys produce 
hydrogen peroxide (H2O2) upon dilution which leads to the production of reactive 
oxygen species. Despite, the potent activity displayed by H2O2, its activity can be 
inhibited by catalase enzyme which is a common component in the wound environment, 
where catalase is released from skin tissues, this may lead to a decrease in the 
antimicrobial activity. Other components can be described as immune modulatory 
molecules include:  phenolic compounds, bee defensing 1 and flavonoid compounds, 
can also contribute to activity in some types of honeys (Alvarez et al., 2014). Role of 
honey and suggested mechanisms are summarized in table 1. 
 
 On the other side, MH unlike other honey types is able to retain its antimicrobial 
activity in the presence of catalase. MH has been famous with its non- peroxide 
antimicrobial effect owing to the presence of methylglyoxal (MGO) (Structure shown 
in figure 5) when research groups identified independently the presence of MGO in MH 
in 2008 (Adams et al., 2008, Mavricks et al., 2008).  MGO is an organic compound that 
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can be called also 2-oxopropanal or pyruvaldehyde. MGO has the formula: CH3C (O) 
CHO. In the gaseous state, MGO has 2 carbonyl groups, an aldehyde and a ketone. 
However, in the presence of water, it is present as hydrates as well as oligomers. MGO 
is considered to be a pyruvic acid reduced derivative. MGO is formed as a side-product 
of several metabolic pathways in organisms. MGO is a component within MH as it was 
shown to have activity against both E. coli and S. aureus and has been shown to be 
responsible for most of the manuka honey’s antimicrobial activity (Mavric. et al., 2008, 
Israili.et al., 2014) and may help the formation of biofilms formed by P. 
aeruginosa (Israili et al.,  2014).   
 
Interestingly, the mechanism by which MH exhibits its antibacterial activity has been 
investigated in S. aureus and Pseudomonas aeruginosa (see figure 6 and figure 7 
respectively). It was shown that MH inhibits S. aureus by interfering with cell division, 
whereas it leads to lysis of P. aeruginosa cells due to the reduction of a key structural 
protein (Jenkins et al., 2015).  
 
In addition to its non-peroxide antimicrobial activity, it was suggested that MH has a 
role in modulating the initial inflammatory response by promoting the production of 
cytokines that regulate the production and the angiogenesis of fibroblasts (Molan 2006, 
Tonks et al., 2007). MH was shown to help in stimulating toll-like receptor 4 on 
monocytes which in turn leads to the stimulation of the production of IL1b, IL6 and 
TNFα from monocytes which are important in tissue repair and regeneration (Tonks et 
al., 2001, 2003, 2007). Other effects that aid in the healing process were mentioned 
such as lowering the pH of wound area. It was reported that MH decreased pH of 
cutaneous wounds (Gethin at al., 2008).  Raising pH of the wound towards acidic was 
suggested to have many effects starting from including a shift to the right to what is 
called the oxygen–haemoglobin dissociation curve, leading to an increase in oxygen 
release, decreased toxicity of end products of bacteria such as ammonia, decreased 
protease activity, activated destruction of abnormal collagen, activated angiogenesis, 
enhanced fibroblast and macrophage activity as well as controlled the enzyme activity 
(Greener et al. 2003, Githen et al., 2008). Suggested mechanisms for honey as well as 
their clinical effects in healing wounds are represented in figure 8. 
In a way to rate MH, a grading system called UMF (Unique Manuka Factor) rating was 
started by the UMF association. The system is supposed to measure the non-hydrogen 
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peroxide antibacterial potency of MH. The higher the UMF number is, the higher the 
efficacy and anti-bacterial activity is. Another rating is (MGO) rating made by the 
Active Manuka Honey Association (AMHA), as MGO content increases as the potency 
and activity of MH increases. UMF rating typically ranges from 10 to 25 while MGO 
rating ranges from 100+ to 850+ (Atrott at al., 2009, Jenkins et al., 2015). 
 
1.8. Electro-spun nanofibrous scaffolds for wound healing 
Electro-spun nanofibrous scaffolds have many applications in the biomedical field 
especially in wound healing and tissue engineering. Main advantages of these special 
fibers include high surface area to volume ratio, high porosity. Other advantages related 
to the electro-spinning process include the wide range of electro-spinable polymers that 
can be used, versatility and flexibility of the electro-spinning process itself and the 
possibility of loading the fibers with bioactive agents, antibacterial agents or functional 
nanoparticles. All these advantages contribute to expanding the use of electro-spun 
nanofibers in wound healing application (Liu et al, 2017). 
 
A desired feature in nanofibrous mat dressings that they can allows for providing a 
temporary structure for skin cells that resembles the native ECM functions, act as an 
adhesive layer for cells, guide the growing tissue and act as mechanical support. The 
three-dimensional (3D) electro-spun nanofibrous scaffolds have been developed to 
produce dressings that resembles the ECM nano sized structure. The highly porous 
nature of electro-spun matrices that resemble a natural ECM are important for the cells 
to restore their shape and restore their normal behavior (Puppi et al., 2011). 
 
Electro-spinning, is a technology used for the formation for electrostatic fibers. The 
resulting fibers usually have diameters that range from several nanometers to several 
micrometers where high voltage electric fields are used in the process. A typical electro-
spinner includes the following: high voltage power supply, spinneret system as well as 
a collecting screen as shown in figure 9. In the process, there are parameters that affect 
the transformation of polymer solutions into nanofibers. These parameters include: a) 
variables like flow rate, voltage used and distance from the needle tip to the collecting 
surface, b) solution properties such as concentration, viscosity, elasticity, conductivity 
and surface tension, (c) ambient parameters like humidity, solution temperature and air 
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velocity in the chamber of the electro-spinner (Huang, Z. M., Zhang, 2003, Vellayappan 
et al., 2016). All parameters are presented in figure 10. 
 
There are many types of drug loading prior to the electro-spinning process (as shown 
in figure 10). The new electro-spinning techniques such as sequential electro-spinning 
and co-axial electro-spinning can contribute in the formation of drug delivery systems 
as they can produce prolonged release of various biomolecules or drugs. In addition, 
near field electro-spinning can produce aligned fibers which can be formed into to 2 or 
3-D scaffolds. These scaffolds are similar to the ECM, and are suggested to help 
scientists to make a tissue engineering breakthrough. 
 
1.9 Poly vinyl alcohol, structure, synthesis and applications 
Poly(vinyl alcohol)  is among the famous hydrophilic synthetic polymers possessing 
good chemical as well as thermal stabilities. It has the chemical formula 
[CH2CH(OH)]n. The structure of PVA is considered a relatively simple structure (shown 
in Figure 11). The monomer (vinyl alcohol) doesn’t exist in a stable state where PVA 
is produced by polymerizing vinyl acetate (VAc) to polyvinyl acetate (PVAC) then this 
step is followed by hydrolysis to PVA.  PVA is generally white in color and odorless. 
It requires heat (> 70℃ ) to obtain complete dissolution in water. The degree of 
hydrolysis affect chemical properties, crystallinity and water solubility of the polymer.  
Commercial grades of the polymer exist with high degrees of hydrolysis (nearly > 
98.5%) (Hassan & Peppas, 2000).  
 
Due to its non-toxicity, biocompatibility and good mechanical properties, PVA has 
been used in many biomedical applications, such as  wound dressings, cardiovascular 
devices ,drug delivery systems and artificial skin, and. Moreover, PVA is considered 
one of the famous electro-spinnable polymers that can be used to develop highly porous 
nanofibrous meshes. This made it easy to load the polymer solutions with a variety of 
other water soluble drugs or polymers taking in consideration adjusting the parameters 
that influences morphology of the formed fibers, such as polymer concentration, 
voltage, flow rate as well as the distance between the tip of the needle and the collecting 
surface (Puppi et al., 2011, Taepaiboon et al., 2006). 
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1.10. Pomegranate peel powder extract 
Pomegranate (Punica granatum L.) is one of the fruits that gained researcher’s interest 
in recent years due to its enormous biological activities. Pomegranate fruit is rich in 
tannins and phenolics which were shown to be responsible for its antioxidant activity. 
Pomegranate juice together with its peel contain remarkable amounts of polyphenolic 
compounds such as ellagic acid, ellagic tannins, flavonols, anthocyanins, catechin, 
procyanidins and gallic acid. The fruit has been used in many pharmaceutical 
preparations like cosmetics, tinctures and other therapeutic formulas. 
 
Pomegranate peel constitutes 50% of the pomegranate fruit weight. The peel was shown 
to have higher amounts of polyphenolic compounds than pomegranate juice and thereby 
possessing even stronger biological activity. Despite this, the peel is often discarded as 
waste. That is why it gained concern in many studies being an abundant and cheap 
source for natural antioxidants. While there is an increased demand on processing of 
pomegranate. Larger amounts of wastes are produced. For each 1 ton of pomegranates 
being processed, 500-550 kg waste peels are produced as a major by-product (Qu et al., 
2009, Tenkler et al., 2018). Under European regulations, pomegranate peel waste 
should not be disposed neither on land nor in landfills because it holds a significant risk 
to watercourses. Therefore, pomegranate peel waste disposal is turning into a major 
problem mainly for pomegranate processing factories (Goula & Lazarides, 2015). 
 
Several studies reported that pomegranate peel powder extract (PPP) had markedly 
higher antioxidant capacity than the pomegranate juice extract in scavenging against 
hydroxyl, peroxyl radicals and superoxide anion. In addition to its antioxidant activity, 
PPP was shown to have a range of other biological actions like anti-cancer activity, 
antimicrobial activity, anti-inflammatory and anti-diabetic activities. A diagram for the 
PPP extracted biomolecules and its suggested enthopharmacological potential in many 
health conditions ranging from acting as a cardiovascular protective agent, anti-
inflammatory and anti-allergic, anti-influenza as well as an antimalarial and effective 
wound healing agent is shown in figure 12 (Ismail  et al., 2012). 
 
In a way to investigate more into PPP wound healing mechanisms, Aslam et al., 
suggested that PPP activated  the synthesis of type I procollagen and led to the inhibition 
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of the production of matrix metalloproteinase-1 (MMP-1; interstitial collagenase by 
dermal fibroblast. (Aslam et al., 2006). 
 
1.11. Bee Venom  
In the past, bee venom (BV)  was not only considered as the main way by which bees 
defend themselves against predators but also it was popular for therapeutic value in 
many ancient civilizations (Babylont, Egypt, Greece and China) (Urtubey, N., 2005). 
Apis mellifera honey BV grabbed attention for the first time in modern history in the 
late 19th century. In 1950, Aberman and Neuman suggested that the venom’s biological 
activity is attributed to the presence of protein and peptide content. In 1963, Benton et 
al. presented an ingenious way for the collection of venom in large quantities. Since 
then BV has been the focus of several scientists unravelling BV composition and the 
biological effects of its components (Banks & Shipolini, R. A.1986).  
The main activity of BV is attributed to melittin protein which constitutes from 40% to 
50% of the dry weight of the venom. Melittin itself has been the focus of many studies 
owing to its potent antimicrobial as well as lytic properties (Banks & Shipolini, 1986). 
Mellitin was found to have cytotoxic activity towards cancer cells as well as being 
acting as a potent anti-inflammatory and anti-arthritic in very small amounts. However 
large doses were reported to be inflammatory and hemolytic. (Oršolić, 2013) 
Many recent studies considered  bee venom (BV) as a promising candidate for wound 
healing owing to its powerful antibacterial effect (Fennell, J. F. et al.,1967 ,Lubke et 
al., 1997, Isam et al., 2015, Lazarev, V., 2005) and potent anti-inflammatory properties 
(Kang et al., 2002, Lee et al., 2005, Lee et al., 2010). Another study also suggested that 
BV in concentration less than 100 μg/ml did not show cytotoxic effects. Bee Venom 
also, activates human epidermal keratinocyte migration and proliferation in vitro (Han 
et al., 2013).  
1.12. Honey powder 
Honey powder is a concentrated form of honey lacking the 20% moisture content. This 
type of honey captured attention for its use in food industry. In contrast to liquid honey 
which is viscous and difficult to disperse, honey powder was a good alternative. Tong 
et al., suggested that honey powder can be used to improve the dough quality and shelf 
life in bread making (Tong et al., 2010). 
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Among the methods to prepare honey powder is spray drying, vacuum drying and 
freeze drying/ lyophilization. Extreme stickiness and high viscosity of liquid honey 
have been the main drive for the increasing demand for the production of dried honey 
powder by food manufacturers and consumers. However, getting honey into the free 
flowing powder form either by freeze or spray drying was reported to be a challenging 
process due to its stickiness and strong hygroscopic property (Adhikari et al., 2009, 
Kruszewski et al., 2014). Some papers reported that inclusion of high molecular weight 
carrier material like whey protein within honey helped to solve this 
problem.(Shi et al., 2013,  Samborska et al., 2015a,b) as  whey protein can modify the 
surface properties of the atomised particles as well as the film‐forming ability of the 
particles during spray drying (Islam et al., 2013, Wang et al., 2013).   
Despite the challenge in achieving the powdered honey form without including 
additives, numerous companies sell pure honey powder. Also, although honey powder 
use is limited to food industry, its efficacy in other fields like wound healing, needs 
investigation. Taking in consideration ease of transportation and storage, being a 
concentrated form of honey and relative cheap price compared to other honey types, 
potential of this form of honey should be addressed through including it in more studies 
to observe its use in fields other than food industry. 
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Chapter 2: Materials and Methods 
 
2.1. Materials  
Poly (vinyl alcohol) (PVA) with MW (molecular weight) ~ 125,0000 and commercial 
name “Mowiol 20-98” was purchased from Sigma Aldrich, Germany. Lyophilized 
multiflora honey was purchased from Xiaocaokeji, China. Manuka honey MGO 550+, 
was purchased from Manuka Health, New Zealand. Methanol (Ultra) gradient HPLC 
grade was purchased from J.T. Baker, Philipsburg, NJ, USA. Pomegranate peel powder 
was purchased from local condiments store.  Glutaraldehyde (GH) solution 50% was 
purchased from Acros Organics, Belgium. RPMI media with L-glutamine, Alkaline 
Phosphate buffer (PBS) and trypsin were purchased from Lonza, Belgium. Thiazolyl 
blue tetrazolium bromide (MTT) was purchased from Sigma Aldrich, Germany. Difco 
Nutrient broth and Difco Nutrient agar were purchased from Thermo Fisher, Germany.  
 
2.2. Experimental Procedures  
2.2.1. Extraction of the pomegranate peel powder 
Extraction of the pomegranate peel powder was done according to a previously 
published protocol (Singh & Jayaprakasha, 2002). The first step was suspending 25 g 
of the pomegranate powder in 100 ml methanol. Stirring was done at room temperature 
for 1 h. The extract was then centrifuged at 4000 rpm for 3 min. The supernatant was 
then diluted with distilled water to ratio (80:20) to decrease the freezing point from -
97℃ to -20℃. The resulting solution was lyophilized using a freeze drying machine 
(TOPT – 10 C Freeze Dryer, China). The process was achieved after keeping the freeze 
drying machine operating for 48 h. The resulting powder was weighed and kept in an 
eppendorf tubes to be used later on.  
 
2.2.2. Preparation of polymer solutions 
Solutions containing different ratios of MH, LH, PPP, BV and PVA were prepared in 
the following concentrations: (10% MH/ 1% PPP/ 12% PVA), (20% MH/ 2% PPP/ 
10.5% PVA), (25% MH/2.5% PPP, 9.7% PVA), (30%/MH/3%PPP/9.7%PVA), (25% 
MH/ 2.5% PPP/ 0.01% BV, 9.7% PVA), (25% LH/ 2.5% PPP/ 0.01%/ BV, 9.7% PVA). 
Honey concentrations used were chosen according to previous data (Sarhan & Azzazy 
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2016). As for BV, it was shown that in concentration less than 100 μg/ml did not show 
cytotoxic effect while activated human epidermal keratinocyte migration and 
proliferation in vitro (Han et al., 2013). According to the later suggestion, BV 
concentration was fixed at 0.01 % in all samples.  In our study, PPP concentration was 
used up to 2.5%.  The extract was not loaded before into nanofibers. However, it has 
been shown that 2.5% PPP gel decreased wound healing time in animal model 
(Chidambara Murthy et al., 2004). PVA was dissolved in deionized water by stirring at 
90℃ for 3 h and then honey and PPP were added where stirring was maintained at room 
temperature for 1h. After adding BV, the polymer jars were covered with aluminum 
foil at room temperature until electro-spinning.  
 
2.2.3. Electro-spinning  
Different voltages were applied to the polymer solutions (Gamma High Voltage Power 
Supply, USA) in order to determine the best voltage for each solution. Adjustment of 
the flow rate was carried out at 1ml/min. The Distance between the collecting plate and 
the nozzle of the electro-spinner (Sustaincubator, Egypt) was adjusted at 12 cm 
throughout the spinning process.  
The concentration of the components of each formula was represented in wt%. After 
stirring each prepared polymeric solution was taken into a 20 ml syringe that was 
attached to a needle. 16-22 KV voltage range was applied to the tip of the needle. The 
electro-spun fibers were collected on an aluminum foil sheet that was covering a non-
moving collector. Electro-spinning parameters were adjusted for each solution, 
depending on trial and error, to obtain the optimum conditions (Table 3). This is 
displayed in the fibers’ morphology as examined by the SEM. All the electro-spinning 
processes were performed at ~30% humidity and ~30 ᵒ C and. After collection, the fibers 
were kept in a dry and cool place to be ready for further steps. 
 
2.2.4. Cross linking of fiber mats 
This step was achieved chemically using GH 25% solution. The fibers were placed in 
a desiccator. The desiccator was further closed after being saturated with GH vapors. 
Fibers’ exposure to the vapors was done at different time intervals (6, 12 and 24 hr).  
After this step, heating was done under vacuum in a vacuum oven (Jeiotech, OV-11, 
South Korea) at 45°C for 24 h. 
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2.3. Characterization of the prepared electro-spun fibrous meshes 
2.3.1. Scanning electron microscopy  
Nanofibers’ morphology was observed using scanning electron microscope (SEM: 
FESEM, Leo Supra 55, Zeiss Inc., Oberkochen, Germany) at an accelerating voltage of 
3 kV. For better quality of the resulting images, some of the samples were sputter-
coated with a gold layer before SEM examination (JEOL JFC-1600 Auto fine coater, 
Japan). Some samples were examined using (SEM Model Quanta 250 FEG (Field 
Emission Gun), FEI Company, Netherlands). All SEM images were then analyzed 
using image analysis software (Image J, National Institutes of Health, USA) where the 
average fiber diameter was determined. 50 random nanofibers for each image were used 
to determine the mean and the standard deviation of fibers diameters.  
 
2.3.2. Swelling and water retention capacity  
Swelling or water retention capacity of each fibrous sample was measured using a 
phosphate buffer saline (PBS) solution at (37°C) for 30 min, 3 h and 7 days where thee 
replicas were used. The mats were weighed after wiping off excess PBS solution that 
adhered on the fibrous mat using a filter paper. Percentages of swelling of the 
nanofibrous samples were calculated using the following equation:  
 
𝐷𝑒𝑔𝑟𝑒𝑒 𝑜𝑓 𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔 (% 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑢𝑝 𝑡𝑎𝑘𝑒) = {(Sw− I) /Sw} ×100  
 
Where Sw is the weight of the swollen sample that was dried by the help of a filter 
paper and I is the initial mass of sample. 
 
2.3.3. Water loss capacity  
Water loss capacity of each sample was measured in a phosphate buffer solution at the 
physiological temperature (37 °C) for 1 h, 7 days and 2 months using three replicas. 
After immersion, fibrous mats were left to dry on filter paper before weighing. The 
percentages of water loss of the fibrous samples were calculated using the following 
equation:  
 
𝐷𝑒𝑔𝑟𝑒𝑒 𝑜𝑓 water loss (% 𝑜𝑓 water loss) = {(I – Sd)/I } ×100  
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Where Sd is the dried mass of the sample after being suspended in PBS and dried at 
40◦C. I is the initial mass of the sample. 
 
2.4. In vitro antibacterial assessment  
Viable cell count method was used in order to evaluate the antibacterial activity of the 
electro-spun fibrous mats. The antibacterial activity was evaluated against both 
bacterial strains, Staphylococcus aureus and Escherichia coli. Each strain was added 
into 20 ml Difco nutrient broth that was adjusted to an optical density of 0.1 at 
wavelength of 625 nm. The following samples were tested against S. aureus: (10% MH/ 
1% PPP), (20% MH/ 2% PPP), (25% MH/2.5% PPP). Based on the results of this 
experiment, the following samples: (25% MH/2.5% PPP), (25% MH/ 2.5% PPP/ 0.01% 
BV) and (25% LH/ 2.5% PPP/ 0.01%, BV) were tested against both S. aureus and E. 
coli where 0.01 g of each fibrous sample was added to each of bacterial organisms’ test 
tubes having 1ml from the nutrient media and bacterial strain mixture. All the fibrous 
scaffolds were UV sterilized for 1 h on each side before the test. The S. aureus and E. 
coli tubes containing the nanofibrous mats and a control tube were incubated at room 
temperature with shaking at 150 rpm. The samples from the bacterial broth as well as 
the control were serially diluted in the nutrient broth medium. After this step, 25 µL 
from some dilutions were spread evenly on nutrient agar plates which were then 
incubated at room temperature for one day. Surviving colonies were counted and 
compared to the control tube colonies numbers.  The experiment was done in triplicate.  
  
2.5. Cytotoxicity assay 
 
L929 mouse fibroblast cells (American Type Culture Collection (ATCC) were used in 
this study to evaluate the toxicity of MH/PPP/PVA, MH/PPP/BV/PVA, 
LH/PPP/BV/PVA nanofibers. The cross-linked and non-cross-linked nanofibrous 
scaffolds were tested. Crosslinking was done through exposing the fibers to GH vapor 
for 24 h, then heating was done under vacuum at 40◦C. The scaffolds were cut into 1 
mg sheets and sterilized by exposing each side of the fibers to UV light for 1 h. The 
extracts were prepared through soaking the scaffolds in culture media containing RPMI 
with L-glutamine and 5 % antibiotic (pen-strept) for one day at room temperature. The 
fibers’ extracts were prepared at a concentration of 1mg/ml.  Cytotoxicity was 
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investigated through adding 1 ml of the scaffolds extracts to the cells cultured in a 24-
well plate.  The cytotoxicity was evaluated using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay. L929 fibroblast cells were seeded in a 24 
well plate (TCPS; Costar®, Corning, NY, USA) at a density of 10,000 cells/well and 
then were incubated in a humidified incubator with 5% CO2 for 2 days at room 
temperature before treatment with the fibers’ extracts. Then, the extract for each fibrous 
sample was added to the cell monolayer inside each well. This step was followed by 1 
day incubation of the cells in CO2 incubator at room temperature and 5% CO2. 
Triplicate wells were chosen for each sample. The assay depends on reducing the 
yellow tetrazolium salt to the purple crystals of formazan as a result of dehydrogenase 
enzymes that are released by the mitochondria of the live and active cells (Vatankhah 
et al, 2014). The number of viable cells present in each well is proportional to the 
amount of purple formazan crystals in this well. After 24 h of incubation, the medium 
in each well was aspirated. Then, 1 ml of MTT solution (5 mg/ml in PBS) was added 
to each well. The plate was incubated at 37 ᵒC for 3 hours, the medium was then 
aspirated where 1 ml DMSO/well were added as a subsequent step. DMSO was 
supposed to dissolve the formazan crystals. The optical absorbance was measured at 
595 nm using a plate reader (SPECTROstar Nano, BMG Labtech, Ortenberg, 
Germany). Cells not treated with the extracts were used as the negative control. Cell 
viability (%) was calculated based on the following equation: 
 
 𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑟𝑎𝑡𝑒 %= Ab 𝑠𝑎𝑚𝑝𝑙𝑒 −𝐴b b𝑙𝑎𝑛𝑘 /𝐴b 𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝐴b 𝑏𝑙𝑎𝑛𝑘 ×100 
 
Where Ab sample is the sample absorbance, Ab blank is the absorbance of blank, Ab 
control is the absorbance of the control. 
 
2.6. In vivo wound healing assay  
Adult female Sprague-Dawley rats (Rattus norvegicus albinus) weighing ≈150-200 gm 
were used and divided into 6 groups. Each group having 4 -7 rats. All groups are 
represented in table 4All animal procedures and care were performed in compliance 
with National Research Council’s Guide for the Care Use of Laboratory Animals, and 
with the national institute of health (NIH) guidelines for the Care and Use of Laboratory 
Animals. 
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Rats were anesthetized with the help of intraperitoneal injection of Ketamine/Xylazine 
(ketamine 40-100 mg/kg IP, xylazine 5-13 mg/kg), while the dorsal hairs of the rats 
were shaved. To create a wound on each animal, a scissors was used to create an 
excisional wound on the dorsal side of each rat’s skin. One circular wound with a 
surface area of ~ 45 mm2 was created on the back surface of each rat. Four groups of 
the rats received treatment dressings while two groups received control dressings (No 
treatment) and (PVA). Photographs were taken for the wounds at different time 
intervals (0, 3, 5, 10 and 14). The wound areas were then measured with the help of 
Image J software (Image J, National Institutes of Health, USA) where the average 
surface area for each wound was determined. 
For histological analysis, wounded tissues were Hematoxylin and Eosin (H&E) as well 
as Masson Trichrome (MT) stained. Their histopathology was observed at days 5 and 
10. Tissue samples were evaluated for enhanced healing for all treatment groups and 
compared to the PVA control group. In addition, a scoring system was developed for 
the groups where the least score was considered the best in terms of enhanced healing 
process. 
 
2.7. Statistical analysis 
GraphPad PRISM software was used for determining significance using anova for 
multiple comparisons among samples/groups and t-test for determining significance 
between each two samples/groups. Moreover, all graphs were done by the help of the 
software and error bars were added to the bar charts after determining mean and 
standard deviation for each sample. The analysis was done on the antibacterial 
assessment results as well as the in vivo wound healing assay results.  
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                                     Chapter 3: Results 
 
3.1. Morphological characterization 
As shown from the SEM images that under the optimized spinning conditions, the fibers 
had random orientation, smooth surface, looked round shaped. No beads were observed 
in the fibers. LH sample showed smaller and more uniform diameter than those samples 
containing MH under the same spinning conditions. Range of fibers’ diameter and mean 
of diameter size is represented in table 4. Figure 13 shows the morphology of the 
samples: (10% MH/ 1% PPP/ 12% PVA),  (25% MH/2.5% PPP/10.5% PVA), (25% 
MH/2.5% PPP/ 9.7% PVA),( 25% MH/ 2.5% PPP/ 0.01% BV, 9.7% PVA) and (25% 
LH/ 2.5% PPP/ 0.01%/BV/ 9.7% PVA) and PVA (10%)  together with the histogram 
graphs showing a relationship between the frequency and fibers’ diameter in nm. 
Figure 14 and 15 shows samples (25% MH/2.5% PPP/ 9.7% PVA) and (25% MH/ 2.5% 
PPP/ 0.01% BV, 9.7% PVA) respectively after cross linking by exposure to GH vapour 
for 24 h followed by drying the samples under vacuum for another 24 h. The images 
show the success of crosslinking. Figure 16 shows samples (10% MH/ 1% PPP), (20% 
MH/ 2% PPP/) and (25% MH/2.5% PPP) as viewed under SEM. 
 
3.2. Swelling and water retention capacity  
The percentages of water uptake capacity of the following samples: (25% MH/2.5% 
PPP/9.7% PVA), (25% MH/ 2.5% PPP/ 0.01% BV/9.7% PVA), (25% LH/ 2.5% PPP/ 
0.01%, BV/9.7% PVA) and PVA (10%) are given in Table 5 The three samples show 
moderate capability for water uptake in comparison to PVA scaffolds which had more 
swelling capacity (see figure 17). 
 
3.3. Water loss capacity 
The percentages of water loss o of the following samples (25% MH/2.5% PPP/ 9.7% 
PVA), (25% MH/ 2.5% PPP/ 0.01% BV/9.7% PVA), (25% LH/ 2.5% PPP/ 0.01%, 
BV/ 9.7% PVA) are given in Table 3. It was shown from the results, an increase in 
water loss capacity in honey incorporated scaffolds in comparison with PVA that 
showed less water loss capacity (see figure 18) 
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3.4. In vitro antibacterial assessment  
In the starting experiment against S. aureus, it was shown that the number of colonies 
decreased with increasing the MH/PPP concentration (see figure 19). Based on this 
result, the sample with the highest concentration (25% MH/2.5% PPP) was selected for 
further experiments.  
In the following experiment, the bacterial colonies were counted in triplicates for each 
of the samples: (25% MH/2.5% PPP), (25% MH/ 2.5% PPP/ 0.01% BV), (25% LH/ 
2.5% PPP/ 0.01%) against S. aureus where the average was determined. All samples 
used in the experiments significantly decreased the number of colonies against S. 
aureus in comparison to PVA and the control tested (P< 0.0001). Figure 20 a) shows a 
graph showing a relationship between the numbers of S. aureus colonies vs. samples 
tested while figure 20 b) shows the agar plates after 24 h incubation for each sample 
including the control. Samples containing BV were slightly more effective than the 
sample without BV (P = 0.0013) while there was no significance observed between 
both samples containing BV (MH/PPP/BV), (LH/PPP/BV). 
When testing the same samples, the average number of E. coli colonies was also 
evaluated in triplicates and a relationship between the average number of E. coli 
colonies and different samples was plotted (see figure 21 a). It was clear from the results 
that the three samples tested showed significant decrease in the number of colonies 
compared to both controls used in the experiments (P< 0.0001). Figure 21 b) shows the 
agar plates after 24 h incubation for each sample and the control. There was no 
significance between samples (MH/PPP) and (MH/PPP/BV) (P= 0.561). However, 
sample (MH/PPP/BV) was slightly more effective than sample (LH/PPP/BV) (P= 
0.0382). 
 
3.5. Cytotoxicity assay: 
Figure 22 shows the cytotoxicities of the following samples: MH/PPP (uncross linked), 
MH/PPP (cross-linked), MH/PPP/BV (uncross linked), MH/PPP/BV (cross-linked), 
LH/ PPP/BV (uncross linked), LH/PPP/BV (cross-linked) scaffolds as assessed by the 
MTT test.  
In the cytotoxicity experiment, the extraction medium of the previously prepared fibers 
for each sample was used to evaluate their cytotoxicities against L929 fibroblast cells. 
All samples showed percent viability ranging from 120 % to 104 %.  
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3.6. In vivo wound healing assay 
The average wound surface area for each group was measured and represented in bar 
charts at three time points (day 3, day 5 and day 10) in figure 23. It was shown from 
the results that MH 25%/PPP 2.5%, MH 25%/PPP2.5 %/ BV 0.01 % and LH 25%/PPP 
2.5 %/BV 0.01 % samples significantly decreased wound surface area compared to both 
controls tested at day 3, day 5 and day 10 (P<0.0001). All treatment groups (MH 
10%/PPP 1%,  MH 25%/PPP 2.5%, MH 25 %/PPP 2.5 %./ BV, LH 25%/PPP 2.5 
%/BV) achieved complete healing by day 10 compared to day 14 in case of both 
controls tested. The appearance of each wound was examined at different time points 
starting with day 0, passing by days 3, 5, 7, 10 and ending with day 14 of treatment. 
Figure 24 shows a macroscopic observation for each wound at day 0, day 5 and day 10 
for the six groups tested (group 1, 2, 3, 4, 5, 6).  Two control groups were used in the 
study PVA (group 5) and No treatment group (group 6). A representative figure shows 
a delayed healing in the two control groups compared to the treatment groups (see 
figure 24).  
 
Histopathological assessment using H&E stain showed that treatment samples had 
better healing than the PVA control group. MH/PPP/BV micrograph showed great 
resemblance to normal skin at day 10 (see figure 25). MT micrographs revealed that at 
day 5 less dense collagen fibers were seen in all groups while denser collagen 
deposition of the treated samples was observed at day 10 when compared to the PVA 
control group at the same time point (see figure 26). A histological scoring system for 
the stained samples is presented in table 8. The scores are represented as follows: − = 
absent, + = scanty, ++ = moderate, +++ = profound.  The scoring of the histologic data 
showed that sample MH/PPP/BV had the best score in terms of most enhanced healing 
effect at day 5 and 10 followed by LH/PPP/BV at the same time points while MH/PPP 
(25%/2.5%) and sample MH/PPP (10%/1%) the same scores at both day 5 and day 10. 
All nanofiber dressings provided decrease in the inflammatory phase, allowed for 
earlier granulation tissue formation and earlier epithelialization. 
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                                    Chapter 4: Discussion 
 
Wounds problem together with their complications put a huge economic burden on 
health care systems especially in developing countries. The current study is an attempt 
to develop an effective nanofibrous wound dressings which meets the demands. Many 
natural components were the focus of our project. Honey, pomegranate peel extract, 
and bee venom are the three natural products that are known for their antibacterial and 
anti-inflammatory properties and have been used throughout history in wound healing. 
 
Among the interesting fruit extracts being known for its superior antioxidant and 
antibacterial effect, is pomegranate peel extract (PPP). The fruit peel is usually being 
discarded as waste in spite of possessing higher amounts of polyphenolic compounds 
than the fruit’s juice and thereby having better biological activity. In the current study, 
multiple formulas were prepared using PPP owing to its anti-inflammatory, antioxidant, 
and antibacterial characteristics that was loaded in honey/PVA nanofiber scaffold in 
different concentrations in order to provide an added wound healing activity to the 
PVA/honey formula.  
 
The methanolic extract of PPP was prepared and used in our study. According to 
Chidambara Murthy et al., methanol extracted the highest amount of antioxidant poly 
phenolic compounds from pomegranate peel in comparison with ethanol and water as 
solvents (Chidambara Murthy et al., 2002).  
 
In wound healing, PPP was investigated in enhancing wound healing in several research 
projects. One study demonstrated that the methanolic extract of the fruit’s peel 
contained a high content of phenolic compounds as well as other constituents. The study 
further aimed at preparing a 10% (wt/wt) gel and investigated its efficacy on Wistar 
rats excision wounds. The results showed that rats that received 5.0% gel treatment 
showed complete healing after 10 days compared to 12 days in those rats treated with 
2.5% and 16-18 days in the rats that received a blank gel (Chidambara et al., 2004). In 
2011, Hayouni et al., investigated the efficacy 5% (w/w) of the methanolic extract of a 
pomegranate peel based-ointment on guinea pigs. The results demonstrated that the PPP 
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ointment significantly promoted wound contraction as well as the period of 
epithelialization as assessed by the biochemical, mechanical and histopathological 
characteristics (Hayouni et al, 2011). 
 
Another study evaluated the activity of PPP gel in cutaneous wounds in diabetic rat 
models. The results showed that the gel significantly shortened healing time as shown 
by histological examination as its use promoted in collagen regeneration, fibroblast 
infiltration, vascularization, and epithelialization. Moreover, PPP gel-treated diabetic 
rats showed promoted the EGF, VGEF and TGF-β1. It also led to a raise in contents of 
hydroxyproline and promoted NO production 
 (Yan et al., 2013). 
  
Later on, MH together with pomegranate peel extract (PPP) were used to prepare four 
formulas having an increasing (MH/PPP) concentration. The formulas were electrospun 
and characterized using SEM. The samples were (10% MH/ 1% PPP12% PVA), (20% 
MH/ 2% PPP/10.5 %PVA), (25%/ 2.5%PPP/9.7%PVA) (30%MH/3%PPP/9.7% PVA). 
SEM analysis showed that fibers displayed a good morphology while the fibers’ 
diameter increased with increasing the MH/PPP concentration. Observing an increase 
in fibers diameter as MH concentration increases is matching previous studies (Minden-
Birkenmaier et al, 2015, Yang et al., 2017).  
 
After examining fibers’ morphology of samples (10% MH/ 1% PPP/12% PVA), (20% 
MH/ 2% PPP/10.5 %PVA), (25%MH/ 2.5%PPP/9.7% PVA), they were tested against 
S. aureus. The results that the antibacterial activity of the MH/PPP combination 
increases as the concentration increases. That is why sample (25%MH/ 2.5% PPP/9.7% 
PVA) was selected for further tests. 
 
Concerning honey, there were numerous studies that compared conventional drugs used 
in wound healing and honey. In these studies honey showed successful results. For 
example, in comparison to silver sulfadiazine, the first drug of choice in treatment of 
burns, honey lead to shorter healing process in partial thickness burns. Also, honey had 
faster healing in comparison with ethoxy- diamino-acridine plus nitrofurazone dressing 
in pressure ulcer patients (Günes & Eser, 2007). In comparison to amniotic membrane 
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dressing, honey impregnated gauze showed faster healing in patients with partial 
thickness burns (9.4 days vs. 17 days) (Subrahmanyam, 1994). 
 
Manuka honey (MH), was used due to its superior activity over other honey types and 
popularity in literature in healing wounds owing to the non-peroxide antimicrobial 
activity (Carter et al., 2016) and being a main component in several FDA approved 
dressings. In 2017, Yang et al., developed MH/Silk Fibroin (SF) fibrous antimicrobial 
wound dressing. The study showed that antibacterial effect of the dressings against, E 
.coli, , S. aureus, P. aeruginosa and MRSA increased with increasing the MH 
concentration (from 10 wt % to 70 wt %) without affecting the excellent biocompatible 
properties of SF and finally enhanced wound healing in animal models while having 
similar results to Aquacel Ag dressings (Yang et al, 2017). Although having very high 
percent of MH (70%) incorporated within the meshes, MH used in this study was of 
low grade MH with UMF 5.  
 
Another study also compared Aquacel Ag dressings to honey/chitosan nanofibers 
scaffolds had similar wound closure rates while having better biocompatibility (Sarhan 
and Azzazy, 2016). In 2015, another study investigated the potential of MH/ poly(ε-
caprolactone (PCL) scaffolds in terms of in vitro wound healing effects. The study 
demonstrated that MH incorporation (10 1, 5, 10, and 20% v/v) within the scaffold 
promoted cell infiltration into it and increased fibroblast proliferation when in direct 
contact with the scaffold dressing. Disc diffusion test demonstrated significant 
antibacterial effect against E. coli (Minden-Birkenmaier et al, 2015) 
 
We also tested a second type of honey, lyophilized multiflora honey powder (LH). 
Using lyophilized honey was interesting in terms of being a concentrated form of honey 
that its use is capturing food industry interest to increase quality of some products. 
Many companies sell the pure form of LH where the price is considered to be cheap in 
comparison to other more expensive honey types like MH. Although it was not reported 
that honey powder was used in field other than food industry. Its interesting features in 
terms of ease of storing and transportation, relative cheap price and being more 
concentrated captured our attention to include in our study. We wanted to formulate 
both MH and LH and observe the differences in the results  
 28 
 
 
Another interesting component that captured attention to include in our study was Bee 
Venom (BV). The venom has been the focus of many research groups for years for its 
powerful therapeutic effect in various pathological conditions ranging from pain, 
rheumatic arthritis and skin diseases as well as tumors.  In spite of offering a great 
potential in dealing with many incurable conditions, the venom is considered as 
cytotoxic to eukaryotic cells. That’s why adopting new attempts to move around these 
limitations is important in order to offer effective solutions for treating many 
challenging disorders all over the world. For example, nanotechnology provides 
promising techniques aiming at providing solutions by which cytotoxic effects of BV 
to eukaryotic cells can be controlled (Oršolić et al, 2012). 
 
BV was added at the least concentration of (0.01 %) was selected for fear of possible 
cytotoxicity. According to one study, BV in concentration >100 μg/ml did not show 
cytotoxic effects. Moreover, it promoted human epidermal keratinocyte migration and 
proliferation (Han et al., 2013).   
 
In a subsequent characterization step, fibrous samples were further tested for swelling 
as well as water loss capacity. All samples showed moderate swelling capacity when 
compared to PVA which had higher swelling capability while honey containing 
scaffolds showed better water loss capacity than PVA. The reason to the observed 
moderate swelling might be due to the fact that honey has a high solubility in water. At 
first, Despite honey is supposed to promote water uptake (MohdZohdi et al., 2011), its 
high solubility in water causes an increase in fibers’ degradation rate. Similar to this a 
study done by Wang et al., 2012 were given the same results in honey incorporated 
gelatine/chitosan hydrogel (Wang, Zhu, Xue, & Wu, 2012). Also, Wessam Sarhan and 
Hassan Azzazy obtained similar results when investigating swelling capacity as well as 
water loss capacity of Honey/Chitosan/ PVA nanofibrous scaffolds. Where honey 
inclusion within the scaffold increased the water loss capacity of the PVA scaffolds 
while showing moderate water uptake capacity in the swelling test in comparison to 
honey free PVA scaffolds (Sarhan and Azzazy, 2015) 
 
In the current study we report that honey based nanofibers showed strong antibacterial 
activity against both gram positive and gram negative organisms tested. Having strong 
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activity of honey based dressings against S. aureus is consistent with a previous study 
that demonstrated that honey/chitosan nanofibers showed pronounced antibacterial 
activity against S. aureus. However, honey/chitosan nanofibers had mild antibacterial 
activity against E. coli although honey used was at higher concentration (40%) than our 
current study (Sarhan and Azzazy, 2015). An explanation to this may be attributed to 
the possible synergistic effect between honey and PPP or may be due to MH 
incorporation. It was reported that MH has a strong antibacterial activity towards E. 
coli (Jenkins et al., 2015). This is consistent with our study’s results where MH 
incorporated samples were slightly more effective than LH incorporated samples. 
However, since a good antibacterial effect was also observed in LH samples, that’s why 
we suggest a possible synergistic effect between honey and PPP that led to a strong 
antibacterial effect against E. coli.  
 
Also it was observed that despite the significant antibacterial activity in comparison to 
both controls tested. Samples containing BV showed a slight increase of activity against 
S. aureus but had no added effect against E. coli. This can be explained from the 
previously reported from data supporting the increased activity of BV against gram 
positive bacteria than gram negative bacteria (Fennell et al., 1967). 
 
In crosslinking using GH, 12, 24 h exposures were favored over 6 h exposure. The 
reason to this is attributed to the observed easy dissolution of the fibers in PBS when 
exposed to GH vapors for 6 h. While 12-24 h exposure assured the desired crosslinking 
result as fibers retained their structure and did not dissolve instantly when submerged 
in PBS. 
 
The three samples were further evaluated for cytotoxicity using MTT assay. Our results 
show that, all samples had 100- 120 % cell viability which indicated that the produced 
fibrous dressings have no significant cytotoxicity towards skin cells.  
 
Based on the cytotoxicity tests, the following samples were chosen for further testing 
on animals: (10% MH/ 1% PPP), (25% MH/2.5%PPP), (25% MH/2.5%PPP/ 0.01 
%BV) (25% LH/2.5 %PPP/ 0.01% BV) (no treatment) and (PVA).  
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In the wound healing assay that was done using excision wound models. Treatment 
groups ((25% MH/2.5%PPP), (25% MH/2.5%PPP/ 0.01 %BV) (25% LH/2.5 %PPP/ 
0.01% BV)) led to a significant decrease in wound surface areas when compared to 
both controls used at day 3 and day 5. However, all treatment groups had wound surface 
area < 2mm  and thereby reached complete healing by day 10 compared to day 14 in 
case of both controls.  
 
On the histological side, all treatment groups showed better healing when compared to 
the PVA control group which displayed poor healing at the two time points tested (day 
5 and day 10). MH/PPP/BV sample showed excellent healing at day 10 where the 
epidermis showed mature collagen deposition resembling normal intact skin. 
 
Taking together our results and previous data, based on the antibacterial test and the 
clinical assessment of the in vivo wound healing assay, we suggest that the use of 
lyophilized honey can also be adopted for the perpetration of future dressings. LH 
incorporated nanofibers were smaller than those having MH and had more uniform 
diameter. Taking in consideration the difference in price, LH can be considered as a 
much cheaper alternative for MH. We also suggest that MH/PPP/BV combination can 
be considered as an effective combination to be used for wound healing. BV at 0.01% 
led to a slight increase in activity against S. aureus and in combination with MH, it 
displayed better healing pattern histologically (MH/PPP/BV). We suggest that more 
experiments should be done in order to confirm the enhanced healing effect of 
MH/PPP/BV combination histologically. Also in further work, BV can be added at 
higher concentrations, with caution and samples should be monitored for possible 
cytotoxicity. Despite both types of honey MH and LH showed similar results in terms 
of decreasing the wound surface area; however a slight increase in activity was 
observed against E. coli in the MH incorporated sample (MH/PPP/BV) than the sample 
containing LH (LH/PPP/BV) in the antibacterial assessment. Moreover, based on the 
histology results, MH/PPP/BV showed slightly better healing pattern than LH/PPP/BV. 
However, further studies are necessary to investigate this effect.  
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Future directions 
 
Further analysis is needed to investigate the potential of honey based nanofibrous 
dressings on more challenging wound types like chronic and diabetic wounds taking in 
consideration comparing MH to other alternative honey types. Further studies are also 
needed for addressing the potential of using LH powder in preparing electro-spun 
nanofiber dressings and wound healing. Natural products used in this study were 
promising. Interestingly, varying the concentration of each component might be having 
a direct impact on both fibers’ morphology as well as, dressings’ effectiveness and 
toxicity. For example, BV concentration can be increased while assessing possible 
cytotoxicity. Also, increasing PPP concentration while decreasing honey concentration 
might display fibers with different morphology and possible increased or decreased 
antibacterial activity. In addition, each component can be loaded alone in increasing 
concentrations within each nanofibrous dressing to have better understanding of each 
component potential in terms of accelerating wound healing and fighting infections. 
Taking in consideration histology results, MH/PPP/BV sample showed the best healing 
pattern. However, further histological analysis should be done to confirm this effect. 
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 Table 1. Role of honey in wound healing and suggested mechanisms (Oryan et al., 2016)  
Role of honey Mechanism 
Anti-microbial H2O2  in all honey types and MGO in case of MH were shown to 
responsible for the antimicrobial activity 
High osmolality 
High osmotic pressure of honey withdraws wound exudate into the 
surface 
Nitric oxide (NO) production 
Presence of NO in honey was suggested to aid in antimicrobial, 
antifungal and antiviral effects of honey 
Increase lymphocytic activity and phagocytosis 
Honey was shown to promote T- lymphocytes and B -lymphocytes 
generation as well as activate neutrophils’ phagocytosis in vitro. In 
addition, it was shown that honey also stimulates monocytes to produce 
cytokines,  
interleukin-6 (IL6), interlukin-1 (ILType equation here.1) and tumor 
necrosis 
factor-a (TNFα) which thereby stimulates the immune response to 
infection. 
 
Antibody production 
Honey was shown to increase antibodies production 
Prostaglandins 
Honey reduces prostaglandin 
concentrations and its inhibitory effect was found to  
increase with time 
Anti-
inflammatory 
Honey was found to decrease the damage caused by reactive oxygen 
species during the inflammatory phase of wound healing thus reducing 
further tissue necrosis and scarring. Moreover, it was shown that honey 
reduces inflammation via inhibiting the NF-kB pathway.  
 
Wound 
debridement 
Applying honey dressing over a wound allows for creating a moist 
environment allowing rapid debridement where high osmotic pressure 
of honey and stimulation of proteases by H2O2 may be among the main 
factors contributing to this effect. 
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Boosting the 
immune system 
Proteins and peptides within honey can help in boosting the immune 
system like the 55 kDa glycoprotein called major royal jelly protein 1 
and another protein called type II arabinogalactan. They were suggested 
to promote the release of TNFα  from monocytes. In additon, NO 
present in honey enables it to enhance the immune system. Another 
factor that contributes to this effect is that honey causes a reduction in 
prostaglandins’ concentration which in turn promotes antibody 
production. Moreover, prebiotic oligosaccharides in honey help to 
enhance the immune responses. Recently, a study by Tonks et al. 
suggested that a identified a 5.8 kDa protein within MH honey and 
reported that it is responsible for stimulating the immune system. 
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Table 2. Manuka honey antibacterial strength and their corresponding values using 
MGO and UMF ratings.  (Atrott et al., 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strength MGO UMF 
Mild 120+ 10-12 
Medium 220 + 13-5 
High 400 + 18-20 
Ultra - high 900+ 32-35 
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Table 3. Electro-spinning parameters that were used for fabricating the nanofibrous 
samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration (wt %) Voltage 
(KV) 
Flow rate 
(ml/h) 
Nozzle 
(mm) 
Distance 
(cm) 
10% MH/ 1% PPP 16 1 25 12 
20% MH/ 2% PPP, 12% PVA 22 1 25 12 
25% MH/2.5% PPP/ 10.5% PVA 22 1 25 12 
25% MH/ 2.5% PPP/ 0.01% BV/9.7 % PVA 22 1 25 12 
25% LH/ 2.5% PPP/ 0.01%/PVA 9.7% 22 1 25 12 
PVA 10% 16 1 25 12 
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Table 4. All groups of rats used in the in vivo wound healing assay  
The table shows four treatment groups and two control groups (PVA and No treatment), the 
number of rats used per group and the corresponding samples used for each group 
 
Groups Samples 
Group 1 ( 5 rats) MH/PPP (25/2.5) wt% 
Group 2 (5 rats) MH/PPP (10/1) wt% 
Group 3 (7 rats) MH/PPP/BV (25/2.5/0.01) wt% 
Group 4 (6 rats) LH/PPP/BV (25/2.5/0.01) wt% 
Group 5  (7 rats) PVA (10) wt% 
Group 6 (4 rats) No treatment 
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Table 5. Range of diameter size in nm as well as mean diameter size for the 
nanofibrous samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Range of diameter 
size (nm) 
Mean diameter size 
10% MH/ 1% PPP 230 -  880 511 ± 178 
25% MH/2.5% PPP 315 - 1678 728.032 ± 320 
 
25% MH/ 2.5% 
PPP/ 0.01% BV 
322- 1848 742.1755 ± 380 
 
25% LH/ 2.5% PPP/ 
0.01%/BV 
371-1030 652± 216 
 
PVA  212- 638 412 ±12 
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Table 6. Swelling capacity of selected nanofibrous samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time (h) 25% MH/2.5% 
PPP/ 0.01BV 
25% LH/ 2.5% 
PPP/ 0.01%, 
BV 
PVA 10% 
1 96 % 50 % 218 % 
4 101 % 52 % 222 % 
24 106.6 % 68 % 250 % 
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Table 7. Water loss capacity of selected nanofibrous samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time  25% MH/ 2.5% 
PPP/ 0.01% BV 
25% LH/ 2.5% 
PPP/ 0.01%, BV 
PVA 10% 
1 h 28.5 % 32% 15.5 % 
7 days 66% 55.5% 41% 
2 months  73% 75.5 % 48% 
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Table 8. Histological scoring system for H&E and MT stained wounded tissues 
The scores are represented as follows:  Necrosis: − = (0) absent, + = (1) scanty, ++ = (2) 
moderate, +++ (3) = profound. Inflammatory cells − = (0) absent, + = (1) scanty, ++ = (2) 
moderate, +++ (3) = profound. Hemorrhage: − = (0) absent, + = (1) scanty, ++ = (2) 
moderate, +++ (3) = profound. Granulation tissue maturation: − = (3) absent, + = (2) 
scanty, ++ = (1) moderate, +++ (0) = profound. Epithelialization: − = (3) absent, + = (2) 
scanty, ++ = (1) moderate, +++ (0) = profound. Collagen fibers maturation: − = (3) absent, 
+ = (2) scanty, ++ = (1) moderate, +++ (0) = profound.  Activated hair follicles: − = (3) 
absent, + = (2) scanty, ++ = (1) moderate, +++ (0) = profound.  
 
S
a
m
p
le
s 
N
ec
ro
si
s 
In
fl
a
m
m
a
to
ry
 
ce
ll
s 
H
em
o
rr
h
a
g
e 
G
ra
n
u
la
t
io
n
 
ti
ss
u
e 
m
a
tu
ra
ti
o
n
 
E
p
it
h
el
ia
li
za
ti
o
n
 
C
o
ll
a
g
en
 
fi
b
er
s 
m
a
tu
ra
ti
o
n
 
A
ct
iv
a
te
d
 
h
a
ir
 
fo
ll
ic
le
s 
T
o
ta
l 
sc
o
re
 
Normal − − − +++ +++ +++ +++ 0 
PVA (10%) 
Day 5 
+++ +++ ++ + − − − 19 
PVA (10%)  
Day 10 
++ +++ + + − − − 17 
MH/PPP (25%/2.5%)  
Day 5 
+++ ++ ++ ++ + + − 15 
MH/PPP (25%/2.5%) 
Day 10 
− ++ + ++ + + + 10 
MH/PPP (10%/1%) 
Day 5 
+++ ++ + + + + − 15 
MH/PPP (10%/1%) 
Day 10 
− ++ + ++ ++ ++ − 10 
MH/PPP/BV (25%/2.5%/0.01%) 
Day 5 
− ++ ++ ++ +++ + − 10 
MH/PPP/BV 25%/2.5%/0.01%) 
Day 10 
− − − +++ +++ +++ ++ 1 
LH/PPP/BV 25%/2.5%/0.01%) 
Day 5 
++ ++ + ++ + + − 13 
LH/PPP/B (25%/2.5%/0.01%) 
Day 10 
− + − +++ +++ ++ ++ 3 
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Figure 1. The global prevelance of wounds by type in 2011 and that expected for 2025. It 
is expected that there will be a significant increase in number of chronic wounds whose wounds 
requires an advanced wound care products (MedMarket diligence). 
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Figure 2. Stages of wound healing: (a) Inflammation step, followed by proliferation step 
and finally (c) remodeling. Inflammation step includes injury of a blood vessel followed by 
coagulation, and acute local inflammatory response with the formation of a clot that helps to 
protect against threatening infections). Proliferation step is characterized by cell migration, 
angiogenesis as well as granulation tissue formation (c) Tissue remodeling step involves the 
formation of a disorganized ECM as is shown in the figure in addition to a slightly elevated 
area with the lack of the normal skin appendages (Stein & Küchle, 2013). 
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Figure 3. Tissue injury of acute wound vs. chronic wounds. On the left, acute injury activates 
blood clotting, aggregation of platelets and migration of macrophages and neutrophils to the injury 
site and a blood clot is formed. On the upper right of the figure, by day 5 after injury and under 
normal conditions, the wound continue the normal healing process with the help of the growing 
granulation tissue. On the lower right of the figure, the wound fails to heal properly due to an 
underlying pathobiology or as a result of a microorganism invasion where the healing process is 
interrupted leading to a chronic wound or ulcer formation (Clark et al., 2007).  
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Figure 4. Methylglyoxal structure. 
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 Figure 5. Suggested mechanism by which MH inhibits S. aureus. MH was found to 
influence cell division later stages where after speta formation is obtained, decreased 
production of murine hydrolase together with being sequestered into an inactive form lead to 
having the two daughter cells remaining attached as the septa are unable to become degraded. 
This eventually leads to cell death (Jenkins et al., 2015). 
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Figure 6. A suggested mechanism by which MH inhibits P. aeruginosa. MH initially causes 
cell envelope destabilization via the down-regulation of Oprf which a key proteins that is 
involved in maintaining cell shape and cell wall stability. Loss of this structural protein leads 
to what is called, membrane blebbing which eventually leads to cell lysis (Jenkins et al., 2015). 
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Figure 7. Suggested modulatory effects of honey throughout the stages of wound healing. 
Clinical effects are on the left of the figure while their suggested mechanisms are on the right 
of the figure (Lee at al., 2011).  
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Figure 8. A diagram showing the process of polymeric nanofibers formation via electro-
spinning, different techniques for electro-spinning and different types of collectors. A 
typical electro-spinner include a high voltage power supply, spinneret system as well as a 
collecting screen. Based on the configuration of the syringe required for loading. There are 
different electro-spinning techniques ranging from co-electro-spinning and passing by side by 
side electro-spinning, coaxial spinning, multi-jet spinning, emulsion spinning and the technique 
of surface immobilization. Different collectors are displayed also which may range from fixed 
or static collector, rotating drum, grid and a rotating disc (Vellayappan et al., 2016). 
 
 
 
Polymer solution 
Drug solution A 
Drug solution B 
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Figure 9 . Parameters affecting the electrospinning process. Parameters include parameters 
related to either the solution, process or surrounding conditions (Vellayappan et al., 2016). 
 
 50 
 
 
 
 
 
 
 
 
 
Figure 10. PVA structure. 
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Figure 11. Potential of pomegranate peel extract (PPP) in treating various health conditions. 
The figure shows graphical representation for the PPP extracted biomolecules and its suggested 
enthopharmacological potential as a cardiovascular protective agent, anti- inflammatory and anti-
allergic, anti-influenza as well as an antimalarial and effective wound healing agent. Moreover, PPP 
was shown to have anti-cancer properties (Ismail, T. et al., 2012). 
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Sample SEM images Histogram 
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Figure 12. Representative SEM images of the corresponding fiber mats, including 
histogram for the diameters of fibers (n≈50). 
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Figure 13. Representative SEM images of the crosslinked (MH/PPP) sample. (a) Cross 
linked MH/PPP mat viewed by SEM: FESEM, Leo Supra 55, Zeiss Inc., Oberkochen, 
Germany) at magnification 1500 X. (b) Cross linked MH/PPP mat viewed by SEM 
Model Quanta 250 FEG (Field Emission Gun), FEI company, Netherlands) at magnification 
1.500 X. (c) Cross linked MH/PPP mat viewed by SEM Model Quanta 250 FEG (Field 
Emission Gun), FEI company, Netherlands) at magnification of 3000 X. 
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Figure 14. Representative SEM image for MH/PPP/BV sample. The image reveals the 
success of the crosslinking process. The sample was viewed by SEM ((SEM: FESEM, Leo 
Supra 55, Zeiss Inc., Oberkochen, Germany)) SEM at magnification OF 1500 X. 
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Figure 15. Representative SEM images of the samples: a) (MH 10%/PPP 1%), b) (MH 
20%/PPP 2%), and (MH 25%/PPP 2.5 %). Samples were viewed using SEM Model Quanta 
250 FEG (Field Emission Gun), FEI Company, Netherlands. 
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Figure 16. A bar chart showing a comparison between the swelling behaviors of the 
electro-spun scaffolds. Honey incorporated samples showed moderate capability for water 
uptake in comparison to PVA scaffolds which had more swelling capacity. 
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Figure 17. A bar chart showing a comparison between the water loss behaviors of the 
electrospun samples. It was shown from the results, an increase in water loss capacity in honey 
incorporated scaffolds in comparison with PVA that showed less water loss capacity. 
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Figure 18. Antibacterial activity against S. aureus increases with increasing in the 
MH/PPP concentration. a) Bar chart showing the relationship between the numbers of S. 
aureus colonies detected vs. samples used in the experiment. It is shown from the chart that 
sample MH/PPP (25%/2.5%) had the greatest activity. b) Agar plates after the experiment. It is 
shown from the figure that as MH/PPP concentration increased, the number of bacterial 
colonies decreased compared to the control used in the experiment after plating the samples 6th 
dilutions. c) Agar plates after the experiment. It is shown from the figure that as MH/PPP 
concentration increased, the number of bacterial colonies decreased compared to the control 
used in the experiment (control and PVA) after plating the samples 7th dilutions.  
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Figure 19. Antibacterial activity against S. aureus. a) Bar chart showing the antibacterial 
activity against S. aureus. It is shown from the figure that the three scaffolds decreased number 
of bacterial colonies compared to both controls used in the experiment (control and PVA) (P < 
0.0001). Samples containing BV were slightly more effective than the sample without BV (P < 
0.05) b) Agar plates after the 24 h incubation. All honey based samples showed significant 
decrease in number of colonies in comparison to both controls tested. 
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Figure 20.  Antibacterial activity against E. coli. a) Bar chart showing the antibacterial 
activity against E. coli. It is shown from the figure that the three scaffolds decreased the number 
of bacterial colonies compared to both controls used in the experiment (control and PVA) (P < 
0.0001). Sample (MH/PPP/BV) was slightly more effective than sample (LH/PPP/BV) (P < 
0.05). b) Agar plates after 24 h incubation. It is shown from the figure that the three scaffolds 
decreased the number of bacterial colonies compared to both controls used in the experiment 
(control and PVA). 
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Figure 21. Cytotoxicity of electro-spun scaffolds. Samples included the following samples 
MH/PPP (uncross-linked), MH/PPP (cross-linked), MH/PPP/BV (uncross-linked), 
MH/PPP/BV (cross-linked), LH/ PPP/BV (uncross-linked), LH/PPP/BV (cross-linked) 
scaffold. All samples did not affect cell viability. 
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Figure 22. Representative graphs showing average wound surface area at day 3, 5 and 10. a) Bar chart 
showing average wound surface areas at day 3. It is shown from the figure that samples MH/PPP (25/2.5) wt %, 
MH/PPP/BV (25/2.5/0.01) wt%, LH/PPP/BV (25/2.5/0.01) wt%, significantly decreased wound surface area 
compared to both controls tested (P< 0.0001). b) Bar chart of the average wound surface areas at day 5.  It is 
shown from the figure that samples MH/PPP (25/2.5) wt%, MH/PPP/BV (25/2.5/0.01) wt%, LH/PPP/BV 
(25/2.5/0.01) wt%,  significantly decreased wound surface area compared to both controls tested (P<0.0001). c) 
Bar chart of the average wound surface areas at day 10. It is shown from the figure that all treatment groups 
(samples MH/PPP (25/2.5) wt%, MH/PPP(10/1) wt%,  MH/PPP/BV (25/2.5/0.01) wt%, LH/PPP/BV 
(25/2.5/0.01) wt%) had a significantly decreased wound surface areas and almost achieved complete healing 
compared to both controls tested (P<0.0001). 
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Figure 23. Images showing healing progression. The images show healing progression from 
day 0 to day 10 for wounds treated with all treatment scaffolds vs. the 2 control scaffolds used 
in this study. It is clear from the pictures that healing was achieved by day 10 in all treatment 
groups unlike slower healing in PVA and no treatment groups. 
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Figure 24. Representative histological assessment for all treatment groups vs. PVA 
control group at day 5 and day 10 as shown by H&E staining (magnification 100 x). a) A 
section in normal skin covered by an intact epidermis is shown. Normal histological structures 
of skin including intact cellular elements in epidermis (arrow), dermis (black star) and 
subcutaneous tissue are shown (red star). b) PVA control group at 5 days showed severe 
epidermal necrosis, ulceration with many necrotic tissue debris infiltrated with inflammatory 
cells (arrow) along with dermal layer severe inflammation. Cells infiltration with congested 
blood vessels and focal areas of hemorrhage were also observed. c) At 10 days the group 
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showed delayed healing with ulcer formation and necrotic tissue debris (arrow) and granulation 
tissue formation (star). d) MH/PPP (25%/2.5%) at day 5 demonstrated incomplete epidermal 
re-epithelialization (arrow) as well as ulcer formation. Diffuse dermal and subcutaneous 
infiltration of inflammatory cells were also observed. e) The same group at 10 days 
demonstrated enhanced healing with complete epithelial bridging across wound gap (arrow). A 
smaller area of highly cellular granulation tissue (star) was observed with moderate 
inflammatory cells infiltrations. f)  MH/PPP (10%/1%) group showed ulcer formation and 
necrotic tissue debris (arrow) as well as granulation tissue formation in dermal layer at 5 days. 
At 10 days, the same group (g) demonstrated enhanced healing process with complete epithelial 
bridging across wound gap (arrow). A decreased area of highly cellular granulation tissue (star) 
was observed with moderate inflammatory cells infiltrations. Some hair follicles were also 
observed. MH/PPP/BV (25%/2.5%/0.01%) group showed good healing at day 5 with complete 
epithelial bridging across wound gap (arrow). However; focal hemorrhagic areas (star) at 
dermo-epidermal junction with extensive dermal inflammatory cells infiltration were observed. 
i) At 10 days the wound of this group revealed accelerated wound healing with complete 
epithelial bridging (arrow), minimal inflammatory cells were observed in dermal layer and 
more activated hair follicles growth (star). j) LH/PPP/BV (25%/2.5%/0.01%) group at 5 days 
showed ulcer formation and necrotic tissue debris (arrow) and granulation tissue formation 
(star). At 10 days (k) demonstrated enhanced healing, complete epithelial bridging (arrow). A 
small area of highly cellular granulation tissue (star) was observed with moderate inflammatory 
cells infiltrations along with some hair follicles growth. 
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Figure 25. Representative histological assessment for all treatment groups vs. PVA 
control group at day 5 and day 10 as shown by Masson Trichrome staining (magnification 
100 x). Abundant mature collagen fibers deposition in dermal layer can be observed in normal 
skin in (a). It is shown from the pictures that at day 5 less dense collagen fibers were seen in all 
groups as seen by grey shades instead of blue color while denser collagen deposition of the 
treated samples: e, g, I, k was observed at day 10 when compared to the control group (c) at the 
same time point.  
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